Initial resultsof the clinical trial with 59 participants showed that using the app reduced anxiety symptoms for many patients; now the new analysis may help identify which patients benefit most.
Initial results of the clinical trial with 59 participants showed that using the app reduced anxiety symptoms for many patients; now the new analysis may help identify which patients benefit most.
A new study has identified the conditions under which the antibody drug bexmarilimab can activate the body's own defence system against cancer, and how to identify patients who will benefit from the drug.
The model could transform patient care, identifying opportunities where early interventions might significantly improve or save lives ... potential health outcomes for patient groups across England.